Rewiring the myeloid cell response to adjuvants to improve tumor control

Ended Project Grant Awarded Last action

Award ID
R01CA244142
Recipient
Awarding agency
Obligated
$5,397,779

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Funding
  • $4,688,195.71 Federal
  • $709,583.00 Non-federal
Place of performance
Oregon, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$22,228 $0
Amendment $18,872 $0
Amendment $18,872 $0
Amendment $339,694 $0
Amendment $339,694 $0
Amendment $339,694 $0
Amendment $30,195 $0
Amendment $30,195 $0
Amendment $30,195 $0
Amendment $339,694 $0
Amendment $339,694 $339,694
Amendment $339,694 $0
Amendment $339,694 $0
Amendment $339,694 $0
Amendment $30,195 $0
Amendment $30,195 $30,195
Amendment $30,195 $0
Amendment $339,694 $0
Amendment $339,694 $339,694
Amendment $339,694 $0
Amendment $18,873 $0
Amendment $358,565 $0
Original award $377,438 $0
Show all 23

Quick answers

Who received award R01CA244142?

R01CA244142 was awarded to Providence Health & Services - Oregon by National Cancer Institute (National Institutes of Health) on December 2, 2019.

How much is award R01CA244142 worth?

$5,397,779 has been obligated on R01CA244142: $4,688,196 in federal funding and $709,583 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award